I had an absolutely delightful time at the SOBCon conference this past weekend, interacting with a great group of very high-quality
FDA to Sepracor on new anti-epileptic drug candidate (STEDESA) – Nah.
FDA to AstraZeneca/Pozen on arthritis drug (VIMOVO) – cleared for takeoff.
Initial Sales Training/Product Training – Getting new pharma/biotech sales reps up to speed is a major challenge. Impactiviti’s partner network has the experienced, high-quality training providers you need. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
For a contrarian industry view – Marcia Angell on Big Pharma, Bad Medicine
Today’s sunrise, from my backyard in Boonton, NJ. Stunning.
JUST FOR FUN
Fire-breathing manholes in Manhattan. I just like the fireman’s quote…!
Visit the Impactiviti Job Board